Table 4.
Associations between country of GP and performance of medication review, the patient as a barrier, and the time requirement as a barrier
| Topic; survey question | Answer choice | Germany (n = 79) | United Kingdom (n = 28) | Italy (n = 32) | Austria (n = 14) | Total (n = 153) | Significance X2 test |
|---|---|---|---|---|---|---|---|
| Performance of medication review; For PRIMA-eDS patients I performed the study medication review… | For some study patients | 23% | 14% | 16% | 7% | 18% | 0.001 |
| For all study patients, but only the medication reviews required for research | 70% | 39% | 59% | 79% | 63% | ||
| For all study patients, and additional medication reviews not required for research | 7% | 47% | 25% | 14% | 19.0% | ||
| Total respondents | 79 | 28 | 32 | 14 | 153 | ||
| Barriers; A barrier to implementing the recommendations is the patient. | Strongly agree | 5% | 14% | 9% | 11% | 8% | 0.009 |
| Agree | 18% | 48% | 43% | 45% | 30% | ||
| Disagree | 31% | 38% | 29% | 22% | 31% | ||
| Strongly disagree | 46% | 0% | 19% | 22% | 31% | ||
| Total respondents | 65 | 21 | 21 | 9 | 116 | ||
| Barriers; A barrier to implementing the recommendations is the time requirement. | Strongly agree | 11% | 5% | 10% | 42% | 13% | 0.000 |
| Agree | 8% | 47% | 35% | 0% | 19% | ||
| Disagree | 50% | 48% | 38% | 33% | 45% | ||
| Strongly disagree | 31% | 0% | 17% | 25% | 23% | ||
| Total respondents | 74 | 21 | 29 | 12 | 136 |
GP: general practitioner; PRIMA-eDS: Polypharmacy in chronic diseases: Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support.